44 Wealth Management LLC Decreases Holdings in The Cigna Group (NYSE:CI)

44 Wealth Management LLC decreased its position in The Cigna Group (NYSE:CIFree Report) by 18.1% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 2,128 shares of the health services provider’s stock after selling 471 shares during the period. 44 Wealth Management LLC’s holdings in The Cigna Group were worth $588,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Oxbow Advisors LLC boosted its stake in The Cigna Group by 17.5% in the 4th quarter. Oxbow Advisors LLC now owns 19,188 shares of the health services provider’s stock worth $5,299,000 after purchasing an additional 2,855 shares in the last quarter. Deseret Mutual Benefit Administrators increased its holdings in The Cigna Group by 6.5% in the 4th quarter. Deseret Mutual Benefit Administrators now owns 800 shares of the health services provider’s stock worth $221,000 after acquiring an additional 49 shares in the last quarter. Hudson Edge Investment Partners Inc. grew its holdings in The Cigna Group by 1.9% during the 4th quarter. Hudson Edge Investment Partners Inc. now owns 1,883 shares of the health services provider’s stock valued at $520,000 after buying an additional 36 shares in the last quarter. Paradigm Asset Management Co. LLC grew its holdings in The Cigna Group by 74.1% during the 4th quarter. Paradigm Asset Management Co. LLC now owns 5,875 shares of the health services provider’s stock valued at $1,622,000 after buying an additional 2,500 shares in the last quarter. Finally, Waterfront Wealth Inc. grew its holdings in The Cigna Group by 36.4% during the 4th quarter. Waterfront Wealth Inc. now owns 3,406 shares of the health services provider’s stock valued at $940,000 after buying an additional 909 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

The Cigna Group Trading Up 0.1 %

Shares of CI opened at $299.92 on Friday. The stock’s 50-day moving average is $286.35 and its two-hundred day moving average is $319.60. The stock has a market cap of $83.42 billion, a PE ratio of 24.50, a P/E/G ratio of 0.98 and a beta of 0.54. The Cigna Group has a 12 month low of $262.03 and a 12 month high of $370.83. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72.

The Cigna Group (NYSE:CIGet Free Report) last issued its quarterly earnings data on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing analysts’ consensus estimates of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same period last year, the firm posted $6.79 EPS. Equities analysts forecast that The Cigna Group will post 29.77 earnings per share for the current fiscal year.

The Cigna Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 20th. Investors of record on Wednesday, March 5th will be paid a $1.51 dividend. This is a boost from The Cigna Group’s previous quarterly dividend of $1.40. The ex-dividend date is Wednesday, March 5th. This represents a $6.04 annualized dividend and a dividend yield of 2.01%. The Cigna Group’s payout ratio is 45.75%.

Analyst Ratings Changes

A number of brokerages recently issued reports on CI. Wells Fargo & Company lowered their price target on The Cigna Group from $370.00 to $341.00 and set an “equal weight” rating for the company in a research report on Tuesday, February 4th. UBS Group cut their price target on The Cigna Group from $410.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, February 3rd. Sanford C. Bernstein lowered The Cigna Group from an “outperform” rating to a “market perform” rating and set a $323.00 price target on the stock. in a research note on Thursday, February 6th. Raymond James reiterated a “strong-buy” rating and issued a $360.00 target price (down previously from $415.00) on shares of The Cigna Group in a research note on Friday, January 31st. Finally, Truist Financial lowered their price target on The Cigna Group from $390.00 to $375.00 and set a “buy” rating for the company in a report on Tuesday, February 4th. Two analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, The Cigna Group has an average rating of “Buy” and an average target price of $373.69.

Get Our Latest Research Report on CI

The Cigna Group Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Further Reading

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.